iiinova — where your digital self keeps evolving

European Medicines Agency @ema.europa.eu · 08/10/2026

📢 From January 2027, a pilot helping sponsors develop stronger clinical trial applications in the EU will become a permanent initiative. This is known as the Accelerating Clinical Trials in the EU (ACT EU) advice 🔗 Learn more www.ema.europa.eu/en/news/clin... #PublicHealth #medsky 🧪 #SciComm

041

European Medicines Agency @ema.europa.eu · 30/09/2026

🧪 EMA will develop a roadmap by end-2026 to drive change in how women’s health is considered in medicines development and regulation. It follows a workshop with 100+ experts and stakeholders. Read more: www.ema.europa.eu/en/news/wome... #medsky #womenshealth

ema.europa.eu

Women are missing from medicines development: EMA’s roadmap for change | European Medicines Agency (EMA)

10 priorities proposed to drive change in medicines for women’s health

12211

European Medicines Agency @ema.europa.eu · 29/09/2026

❤️ This World Heart Day, hear personal experiences of living with heart conditions, alongside simple tips on how to look after your heart and take care of your cardiovascular health. Learn more about the EMA workshop: www.ema.europa.eu/en/events/em...

youtube.com

Take care of your heart

YouTube video by European Medicines Agency

063

European Medicines Agency @ema.europa.eu · 24/09/2026

Discover our new pharmacogenomics webpage, featuring information on how genetic variation can influence a response to medicines. Explore data from centrally authorised medicines and scientific guidance for medicine developers 🔗 www.ema.europa.eu/en/human-reg... #PublicHealth #medsky 🧪 #SciComm

ema.europa.eu

Pharmacogenomics | European Medicines Agency (EMA)

Information on pharmacogenomics, including pharmacogenomic information in centrally authorised medicines and scientific guidelines for medicine developers.

0188

European Medicines Agency @ema.europa.eu · 22/09/2026

🌿 Herbal medicines have a long history. Watch the joint FDA/EMA workshop on herbal medicinal and botanical products to find out how regulators ensure their quality, safety and good use 📺 www.ema.europa.eu/en/events/re... @fda.gov

083

European Medicines Agency @ema.europa.eu · 21/09/2026

EMA experts explore why we shouldn't focus on setting a requirement for a number of clinical trials. One pivotal trial, or two? What matters is generating evidence that addresses patients’ needs and supports a positive benefit–risk balance. Read the article: www.nature.com/articles/s41...

nature.com

Two trials or not two trials? That should not be the question - Nature Reviews Drug Discovery

Nature Reviews Drug Discovery - Two trials or not two trials? That should not be the question

5144

European Medicines Agency @ema.europa.eu · 21/09/2026

Both studies were conducted through DARWIN EU, the network that uses real-world healthcare data from across Europe to generate evidence that can support decisions about medicines. Find out more: www.ema.europa.eu/en/about-us/...

ema.europa.eu

Data Analysis and Real World Interrogation Network (DARWIN EU) | European Medicines Agency (EMA)

The Data Analysis and Real World Interrogation Network (DARWIN EU®) provides timely and reliable evidence on the use, safety and effectiveness of medicines for human use.

090

European Medicines Agency @ema.europa.eu · 21/09/2026

What happens after diagnosis? A second looked at treatments received following an Alzheimer’s diagnosis and outcomes including healthcare use, hospitalisations, caregiver support, nursing home or hospice admission and survival. 🔗https://catalogues.ema.europa.eu/node/4731/administrative-details

catalogues.ema.europa.eu

DARWIN EU® - Treatment characterisation and post-diagnosis outcomes in Alzheimer’s disease | HMA-EMA Catalogues of real-world data sources and studies

020

European Medicines Agency @ema.europa.eu · 21/09/2026

Who is affected by Alzheimer’s disease? One study looked at the incidence and prevalence of Alzheimer’s disease, as well as the demographic and clinical characteristics of people newly diagnosed using data from 5 countries. 🔗https://catalogues.ema.europa.eu/node/4730/administrative-details

catalogues.ema.europa.eu

DARWIN EU® - Alzheimer’s Disease: Incidence, Prevalence, and Individuals' Characteristics | HMA-EMA Catalogues of real-world data sources and studies

020

European Medicines Agency @ema.europa.eu · 21/09/2026

On World Alzheimer's Day, we’re highlighting two studies commissioned by EMA that use real-world healthcare data to better understand Alzheimer’s disease, from who is affected to what happens after diagnosis. Keep reading the thread👇 🧪 #medsky #Scicomm

4195

European Medicines Agency @ema.europa.eu · 18/09/2026

📢 EMA recommends: 12 new medicines for approval, including four medicines for cancer. Read more here: 🔗 www.ema.europa.eu/en/news/meet... #PublicHealth #medsky 🧪 #SciComm

0144

European Medicines Agency @ema.europa.eu · 17/09/2026

Did you know some foods and drinks can affect how your medicine works? 🍊☕🍌 Your package leaflet tells you what to be mindful of, including foods, drinks and alcohol. When in doubt, ask your pharmacist or doctor. Keep safe. Read the leaflet.🧪 #SciComm Learn more: www.ema.europa.eu/en/about-us/...

youtube.com

Medicine leaflets

YouTube video by European Medicines Agency

0133

European Medicines Agency @ema.europa.eu · 14/09/2026

The agenda of EMA's human medicines committee #CHMP is now published. Find out what medicines will be discussed this month 💊💉 www.ema.europa.eu/en/events/co... The committee highlights will be released on Friday.

ema.europa.eu

Committee for Medicinal Products for Human Use (CHMP): 14-17 September 2026 | European Medicines Agency (EMA)

091

European Medicines Agency @ema.europa.eu · 04/09/2026

We have just started a review of injectable iron-containing medicines following concerns about the risk of low blood phosphate levels and related bone problems. Find out more in #PRAC highlights: www.ema.europa.eu/en/news/meet...

ema.europa.eu

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 31 August - 3 September 2026 | European Medicines Agency (EMA)

PRAC starts safety review of injectable iron-containing medicines

0134

European Medicines Agency @ema.europa.eu · 04/09/2026

Good news! A new EU supply chain has been put in place to end the shortage of Visudyne, a medicine used to treat adults with certain serious eye conditions, which will ensure access to patients across the EU. Find out more more: www.ema.europa.eu/en/news/new-...

ema.europa.eu

New EU supply chain to end Visudyne shortage | European Medicines Agency (EMA)

Critical shortage of eye medicine expected to be resolved in 2027.

0163

European Medicines Agency @ema.europa.eu · 03/09/2026

🎙️ New #InsideEMA episode! What is it like to be an EMA trainee? From regulatory science and policy to learning, networking and life in Amsterdam, current trainees share their experience of working at the European Medicines Agency. 🎧 💊 🌍

youtu.be

Inside EMA: The EMA traineeship experience

YouTube video by European Medicines Agency

054

European Medicines Agency @ema.europa.eu · 01/09/2026

🚀 We are launching a new voluntary data submission pilot for innovative alternatives to animal testing. Companies can submit data generated using new approach methodologies and receive tailored scientific feedback from EMA 👉 www.ema.europa.eu/en/news/volu... #PublicHealth #medsky 🧪 #SciComm

0162

European Medicines Agency @ema.europa.eu · 19/08/2026

What are the regulatory research priorities for #AI use in the #medicine lifecycle in the EU❓ Find out now from this open-access article: ascpt.onlinelibrary.wiley.com/doi/10.1002/... #medsky #AIResearch 🧪

Conceptual image with a white capsule pill with digital data streams flowing from the medication

084

European Medicines Agency @ema.europa.eu · 13/08/2026

“We need to think about strategies to make #vaccination easier, not more complicated,” said Marco Cavaleri, our head of public-health threats, in a Nature article on combined MMR vaccines versus separate #measles, mumps and rubella shots in children. Read more: www.nature.com/articles/d41... 🧪

nature.com

Trump wants MMR vaccine split up: the science behind why it’s a bad idea

Numerous studies have shown that separating childhood jabs will delay protection and increase costs for families.

23614

European Medicines Agency @ema.europa.eu · 12/08/2026

Questions about childhood vaccination❓Combined measles, mumps and rubella (MMR) vaccines have been used worldwide for several decades to effectively protect children against these diseases. Their safety profile is well-established. Read more: www.ema.europa.eu/en/human-reg... #medsky 🧪

Little girl in pink shirt has a plaster placed on her arm by nurse hands in blue gloves following vaccination.

12916

Reposted by European Medicines Agency

European Centre for Disease Prevention and Control @ecdc.europa.eu · 10/08/2026

Since 2022, #ECDC & @ema.europa.eu have been working together through the VMP to generate evidence on the effectiveness and safety of vaccines used in Europe. The evidence supports public health and regulatory decision-making across the EU/EEA.

295

Reposted by European Medicines Agency

European Centre for Disease Prevention and Control @ecdc.europa.eu · 10/08/2026

𝗛𝗼𝘄 𝗱𝗼 𝘄𝗲 𝗸𝗻𝗼𝘄 𝗵𝗼𝘄 𝘄𝗲𝗹𝗹 𝘃𝗮𝗰𝗰𝗶𝗻𝗲𝘀 𝘄𝗼𝗿𝗸 𝗼𝗻𝗰𝗲 𝘁𝗵𝗲𝘆 𝗮𝗿𝗲 𝗶𝗻 𝘂𝘀𝗲? That's one of the questions the Vaccine Monitoring Platform (VMP) helps answer ➡️ www.ecdc.europa.eu/en/about-ecd... Today a research agenda for 2026–2029 was published, setting out the priority diseases & research questions.

1127

European Medicines Agency @ema.europa.eu · 05/08/2026

A few days on, we're still reflecting on an unforgettable WorldPride Amsterdam. 🌈 EMA became the first EU agency to join a WorldPride event, sailing with our United for Health boat. Together, we showed that inclusive science makes health better for everyone. 💙 Read more:

ema.europa.eu

United for health at WorldPride 2026 | European Medicines Agency (EMA)

The European Medicines Agency (EMA) celebrated diversity, equality and inclusion in public health during Amsterdam's World Pride Canal Parade.

0387

European Medicines Agency @ema.europa.eu · 27/07/2026

🎙️ New Inside EMA podcast: Can medicines one day be developed without animal testing? Discover how innovation and the 3Rs (replace, reduce, refine) are helping shape the future of medicines development while protecting patient safety. 🎧 Listen now

youtu.be

Inside EMA: Better science, better medicines: how innovation is reshaping animal testing

YouTube video by European Medicines Agency

084

European Medicines Agency @ema.europa.eu · 17/07/2026

We're looking for a Clinical Trials Data Management Specialist to join our team in Amsterdam. If you have at least 3 years' relevant experience, and skills in clinical trial data management or statistical programming then apply now! careers.ema.europa.eu/job/EMA-Amst...

075

Reposted by European Medicines Agency

Health Policy Watch - Global health news reporting @healthpolicywatch.bsky.social · 15/07/2026

Cervical cancer kills hundreds of thousands of women, although much of it is preventable. Equitable vaccine design must reflect the HPV types driving disease in the highest-burden populations. INSIDE VIEW: Dr Marco Cavaleri @ema.europa.eu 📖 ➡️ & 🔁🙏 healthpolicy-watch.news/a-regional-a...

0137

European Medicines Agency @ema.europa.eu · 15/07/2026

Innovation thrives through collaboration. We're strengthening our partnership with EISMEA to support Europe's health innovators. Together, we'll help researchers, start-ups and SMEs bring safe, effective health solutions to patients faster. Read more: www.ema.europa.eu/en/news/ema-...

ema.europa.eu

EMA and EISMEA boost cooperation to accelerate health innovations | European Medicines Agency (EMA)

Cooperation will encourage the development of innovative medicines and health solutions for patients

092

European Medicines Agency @ema.europa.eu · 07/07/2026

The European Medicines Agency is looking for a Communication Officer to join our team in Amsterdam. If you have at least 2 years' experience in communications, strong writing skills in English and experience in web, media relations or social media, apply now! careers.ema.europa.eu/job/EMA-Amst...

086

European Medicines Agency @ema.europa.eu · 03/07/2026

This week marked 20 years of EMA’s Patients’ and Consumers’ Working Party – two decades of partnership, progress and patient-centered impact. Since its creation in 2006, it has helped ensure their perspectives are meaningfully reflected in medicines regulation in the EU. Thank you

0131

European Medicines Agency @ema.europa.eu · 02/07/2026

Women live longer, but often spend more years in poor health. EMA is working to support medicines that are better tailored to women’s needs. Join our Women’s Health Workshop (📆28–29 Sept) and help shape a more inclusive future. #medsky 🧪 #womenhealth www.ema.europa.eu/en/news/ema-...

ema.europa.eu

EMA steps up efforts on medicines for women’s health | European Medicines Agency (EMA)

Initiatives to map gaps, challenges and prioritise further actions

0204

European Medicines Agency @ema.europa.eu · 26/06/2026

🧪 How does EMA's PRIME scheme help accelerate medicine development? Watch our new video where Kevin Cunningham (EMA PRIME Scientific Coordinator) and Outi Mäkki-Ikola (Finnish Medicines Agency Fimea) explain how PRIME supports innovation and faster patient access to medicines.

youtu.be

Priority Medicines (PRIME): Medicines targeting unmet medical needs

YouTube video by European Medicines Agency

031

European Medicines Agency @ema.europa.eu · 26/06/2026

📢 EMA recommends: 6 new medicines for approval, including one medicine for Parkinson's disease. Read more here 🔗 www.ema.europa.eu/en/news/meet... #PublicHealth #medsky 🧪 #SciComm

1225

European Medicines Agency @ema.europa.eu · 23/06/2026

Up to 90% of pregnant or breastfeeding women use medicines, yet safety data is limited for many treatments. In our latest podcast, EMA’s Corinne de Vries discusses why this gap exists and how we can build better evidence for informed decisions. 🎙️

youtu.be

Inside EMA: Evidence for two: medicines in pregnancy and breastfeeding.

YouTube video by European Medicines Agency

0144

Reposted by European Medicines Agency

European AIDS Treatment Group @eatgroup.bsky.social · 22/06/2026

EATG is proud to announce its participation in the European Medicines Agency’s (EMA) “United for Health” float during the #WorldPride2026 Canal Parade in Amsterdam on 1 August 2026. Read more: www.eatg.org/news/eatg-to... @ema.europa.eu

eatg.org

EATG to Join EMA’s “United for Health” Float at WorldPride 2026 | EATG

EATG is proud to announce its participation in the European Medicines Agency’s (EMA) “United for Health” float during the WorldPride 2026 Canal Parade in Amsterdam on 1 August 2026.

041

Reposted by European Medicines Agency

EU Science, Research & Innovation @scienceinnovation.ec.europa.eu · 19/06/2026

(1/4) The European Union has been training researchers for 30 years 🧪 This is also a story about Nobel Prize scientist Marie Skłodowska-Curie: link.europa.eu/CmWVpd Curious to know more? Curiosity was her main trait 👇

link.europa.eu

Science without borders: the lasting legacy of Marie Skłodowska-Curie

Nearly a century after her death, Marie Skłodowska-Curie remains one of science’s most enduring symbols of curiosity and discovery. The breakthroughs she made in radioactivity transformed medicine and...

12517

European Medicines Agency @ema.europa.eu · 12/06/2026

We have just concluded that the evidence of potential risk of neurodevelopmental disorders in children born to men treated with #valproate is inconsistent, so existing precautions should be maintained for male patients. Find out more in #PRAC highlights: www.ema.europa.eu/en/news/meet... #MedSky 🧪

ema.europa.eu

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 June 2026 | European Medicines Agency (EMA)

PRAC concludes evaluation of new data regarding potential risk of neurodevelopmental disorders in children born to men treated with valproate

0125

European Medicines Agency @ema.europa.eu · 11/06/2026

EMA's 2025 annual report is now published! Marking the year of our 30th anniversary, in 2025 we recommended 104 human medicines and 30 veterinary medicines. Explore now and interact with the digital report on any device 👇 www.ema.europa.eu/en/news/emas... #MedSky 🧪

ema.europa.eu

EMA’s 2025 annual report shows strong approval numbers for human and veterinary medicines | European Medicines Agency (EMA)

Report highlights progress in science, medicines and health in 2025

082

European Medicines Agency @ema.europa.eu · 03/06/2026

EMA and African regulators are coordinating on the Bundibugyo virus Ebola outbreak in DRC and Uganda. With no authorised vaccines or treatments for this strain, experts are discussing clinical trial designs to advance promising candidates. www.ema.europa.eu/en/news/ema-...

ema.europa.eu

EMA, AMA and African regulatory authorities join forces on Ebola outbreak response | European Medicines Agency (EMA)

Experts discuss clinical trials, treatments and vaccines

0244

European Medicines Agency @ema.europa.eu · 03/06/2026

Data, AI & medicines regulation in Europe: BfArM and EMA discuss how AI, real-world data and the European Health Data Space are shaping regulatory science and public health. 🎥 Watch for key insights www.youtube.com/watch?v=Oghy...

youtube.com

BfArM and EMA: Data, AI and medicines regulation in Europe

YouTube video by European Medicines Agency

062

European Medicines Agency @ema.europa.eu · 01/06/2026

We have a big announcement! EMA will be part of the 2026 celebrations of World Pride in Amsterdam. We believe that health is for everyone, and that diversity and inclusion make science better. Catch us in the Canal Parade on 1 August! Find out more: link.europa.eu/xCRD8K #loveisthebestmedicines

ema.europa.eu

United for Health: EMA in WorldPride 2026 | European Medicines Agency (EMA)

Science and health belong to everyone

0264

European Medicines Agency @ema.europa.eu · 29/05/2026

Better data for better medicines - how is the EU medicines regulatory system transitioning to a data-driven ecosystem to accelerate medicines development to the benefit of #patients? Find out from this article in Nature Reviews Drug Discovery. www.nature.com/articles/d41... #SciComm 🧪

092

European Medicines Agency @ema.europa.eu · 28/05/2026

New Inside EMA episode 🎙️ How can real-world data improve medicine safety and effectiveness and build trust in regulation? Featuring Peter Arlett and Denise Umuhire. 🎧 Tune in now

youtu.be

S01E07 Data trust and the future of medicines

YouTube video by European Medicines Agency

092

European Medicines Agency @ema.europa.eu · 26/05/2026

New procurement procedure for our #DarwinEU project delivering real-world evidence on #medicines. Interested? Submit your request by 15 June via our website: www.ema.europa.eu/en/about-us/... #medsky #realworlddata

040

European Medicines Agency @ema.europa.eu · 22/05/2026

The European Medicines Agency has recommended the first oral GLP-1 treatment for weight management, offering an alternative to weekly injections. Find out more 👇 www.ema.europa.eu/en/news/firs...

0175